RSS
Site-directed Enzyme Enhancement Therapy (SEE-Tx)
Minoryx spins off therapeutic platform to identify next-gen pharmacological chaperones
Clinical stage biotech company, Minoryx Therapeutics, has revealed it is spinning off its Site-directed Enzyme Enhancement Therapy (SEE-Tx) platform into a new company, Gain Therapeutics Read more
